{
    "clinical_study": {
        "@rank": "26799", 
        "arm_group": [
            {
                "arm_group_label": "Commercial Treatment Planning Software", 
                "arm_group_type": "Active Comparator", 
                "description": "Approved treatment planning software"
            }, 
            {
                "arm_group_label": "VSS-Rx1 OPM software", 
                "arm_group_type": "Experimental", 
                "description": "Investigational treatment planning software"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this clinical trial is to demonstrate that treatments generated by an\n      investigational algorithm reduces spherical aberration compared to currently available\n      iDesign treatments."
        }, 
        "brief_title": "New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction for Myopia", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Myopia", 
            "Astigmatism"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Astigmatism", 
                "Myopia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female at least 18 years of age at the time of preoperative exam\n\n          -  Best Spectacle Corrected Visual Acuity (BSCVA) of 20/20 or better\n\n          -  Demonstration of refractive stability\n\n          -  Anticipated postoperative stromal bed thickness of at least 250 microns\n\n          -  Willing and able to return for all study examinations\n\n        Exclusion Criteria:\n\n          -  Pregnant, breast-feeding, or intend to become pregnant over the course of the study\n\n          -  Concurrent use of topical or systemic medications that may impair healing\n\n          -  History of prior intraocular or corneal surgery, active ophthalmic disease, or other\n             ocular abnormality\n\n          -  Evidence of keratoconus, corneal irregularity, or abnormal topography in the\n             operative eye(s)\n\n          -  Known sensitivity or inappropriate responsiveness to any of the medications used in\n             the postoperative course"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01988415", 
            "org_study_id": "STAR-114-SARA"
        }, 
        "intervention": [
            {
                "arm_group_label": "VSS-Rx1 OPM software", 
                "intervention_name": "VSS-Rx1 OPM software", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Commercial Treatment Planning Software", 
                "intervention_name": "iDesign Advanced CustomVue wavefront-guided LASIK treatment", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bogota Laser, Bogota", 
                    "country": "Colombia"
                }, 
                "name": "Gustavo Tamayo, M.D."
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Colombia"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "eugenia.thomas@amo.abbott.com", 
            "last_name": "Eugenia Thomas, O.D.", 
            "phone": "714-247-8723"
        }, 
        "overall_official": {
            "affiliation": "Medico Oftalmologo", 
            "last_name": "Gustavo Tamayo, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Residual uncorrected power (spherical aberration)", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01988415"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Uncorrected and best-corrected distance visual acuity", 
            "safety_issue": "No", 
            "time_frame": "3 Months"
        }, 
        "source": "Abbott Medical Optics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Medical Optics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}